ArticleEcancermedicalscience2020

Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic.

Covadonga Martí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.